Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Haemonetics Corporation (HAE) position

Yes: as of Q1 2026, Jim Simons holds 43K shares of HAE worth $2.4M (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$2.4M
Shares held
43K
% of portfolio
0.0%
Est. average buy price (i)
$65.13
Quarter-end price
$56.36

Estimated trade prices

Average price in quarters with purchases
$79.36
Average prices in quarters with sales
  • Q3 2024: $80.79 (14K shares sold)
  • Q4 2023: $86.45 (104K shares sold)
  • Q3 2021: $63.10 (471K shares sold)

HAE price vs Simons's position

1Y 3Y 5Y MAX
Dates
$40$60$80$10020222023202420252026Sold 471K shares (78.4%) · Q3 2021. Average closing price $63.10 · Price range $57.60–$70.59471KsharessoldNew position of 22K shares · Q1 2022. Average closing price $54.38 · Price range $43.77–$63.2222KsharespurchasedAdded 18K shares (81.4%) · Q2 2022. Average closing price $59.18 · Price range $49.27–$66.0818KsharespurchasedNew position of 3K shares · Q4 2022. Average closing price $80.38 · Price range $74.55–$86.143KsharespurchasedAdded 2K shares (62.5%) · Q1 2023. Average closing price $80.95 · Price range $72.75–$90.602KsharespurchasedAdded 66K shares (over 1,000%) · Q2 2023. Average closing price $84.55 · Price range $80.84–$89.4566KsharespurchasedAdded 71K shares (99.3%) · Q3 2023. Average closing price $89.28 · Price range $82.56–$93.4971KsharespurchasedSold 104K shares (72.9%) · Q4 2023. Average closing price $86.45 · Price range $80.59–$92.61104KsharessoldNew position of 56K shares · Q2 2024. Average closing price $87.97 · Price range $81.24–$97.3756KsharespurchasedSold 14K shares (24.3%) · Q3 2024. Average closing price $80.79 · Price range $72.45–$91.5814KsharessoldNew position of 43K shares · Q1 2026. Average closing price $65.13 · Price range $54.04–$84.0443Ksharespurchased
Average closing price · filing quarter
$65.13
Price range · filing quarter
$54.04 – $84.04
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 New +43K +$2.8M – 43K May 14, 2026
Q3 2024 Reduced −14K −$1.1M −24.3% 42K Nov 13, 2024
Q2 2024 New +56K +$4.9M – 56K Aug 9, 2024
Q4 2023 Reduced −104K −$9.0M −72.9% 38K Feb 13, 2024
Q3 2023 Added +71K +$6.3M +99.3% 142K Nov 14, 2023
Q2 2023 Added +66K +$5.6M +1,273.1% 71K Aug 11, 2023
Q1 2023 Added +2K +$162K +62.5% 5K May 12, 2023
Q4 2022 New +3K +$257K – 3K Feb 13, 2023
Q2 2022 Added +18K +$1.1M +81.4% 40K Aug 12, 2022
Q1 2022 New +22K +$1.2M – 22K May 13, 2022
Q3 2021 Reduced −471K −$30M −78.4% 130K Nov 12, 2021
Q2 2021 First covered – – – 600K Aug 13, 2021
Q1 2021 First covered – – – 1.3M May 13, 2021
Data through Q1 2026 · filed May 14, 2026
13 grouped rows from 13 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own HAE?

Yes. As of Q1 2026, Jim Simons disclosed 43K shares of HAE, worth $2.4M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy HAE?

Jim Simons held HAE since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell HAE?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in HAE. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of HAE does Jim Simons own?

Jim Simons disclosed 43K shares of HAE as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for HAE?

Jim Simons's estimated average buy price for HAE is $65.13, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.